You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

PHENTOLAMINE MESYLATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Phentolamine Mesylate patents expire, and when can generic versions of Phentolamine Mesylate launch?

Phentolamine Mesylate is a drug marketed by Hikma and Precision Dose Inc and is included in two NDAs.

The generic ingredient in PHENTOLAMINE MESYLATE is phentolamine mesylate. There are four drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the phentolamine mesylate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Phentolamine Mesylate

A generic version of PHENTOLAMINE MESYLATE was approved as phentolamine mesylate by HIKMA on March 11th, 1998.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for PHENTOLAMINE MESYLATE?
  • What are the global sales for PHENTOLAMINE MESYLATE?
  • What is Average Wholesale Price for PHENTOLAMINE MESYLATE?
Drug patent expirations by year for PHENTOLAMINE MESYLATE
Drug Prices for PHENTOLAMINE MESYLATE

See drug prices for PHENTOLAMINE MESYLATE

Recent Clinical Trials for PHENTOLAMINE MESYLATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of AlbertaPhase 4
Cairo UniversityPhase 3
University of AlbertaN/A

See all PHENTOLAMINE MESYLATE clinical trials

Pharmacology for PHENTOLAMINE MESYLATE
Medical Subject Heading (MeSH) Categories for PHENTOLAMINE MESYLATE

US Patents and Regulatory Information for PHENTOLAMINE MESYLATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hikma PHENTOLAMINE MESYLATE phentolamine mesylate INJECTABLE;INJECTION 040235-001 Mar 11, 1998 AP RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Precision Dose Inc PHENTOLAMINE MESYLATE phentolamine mesylate INJECTABLE;INJECTION 207686-001 Jul 14, 2017 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.